Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Annals of the New York Academy of Sciences
|
May 13, 2015
FCRL regulation in innate-like B cells
Randall S Davis
Annual Review of Immunology
|
January 5, 2007
Fc receptor-like molecules
Randall S Davis
Frontiers in Immunology
|
November 9, 2020
Roles for the FCRL6 Immunoreceptor in Tumor Immunology
Randall S Davis
JAMA
|
January 6, 2011
Unraveling the molecular pathogenesis of chronic lymphocytic leukemia: dissecting a microRNA regulatory network
Daniel J Allendorf, Randall S Davis
Proceedings of the National Academy of Sciences of the United States of America
|
March 20, 2013
FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling
Zilu Zhu, Ran Li, Hao Li, et al.
Leukemia & Lymphoma
|
October 14, 2014
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
Racquel D Innis-Shelton, Randall S Davis, Lawrence Lamb, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Evidence for Extensive Duplication and Subfunctionalization of <i>FCRL6</i> in Armadillo (<i>Dasypus novemcinctus</i>)
Maria Carolina Matos, Ana Pinheiro, Randall S Davis, et al.
Blood
|
September 13, 2011
FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling
Hae Won Sohn, Peter D Krueger, Randall S Davis, et al.
Clinical Case Reports
|
June 8, 2017
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia
Lauren K Shea, Fady M Mikhail, Andres Forero-Torres, et al.
European Journal of Immunology
|
November 11, 2008
FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia
Daniel M Schreeder, Jicun Pan, Fu Jun Li, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Annals of the New York Academy of Sciences
|
May 13, 2015
FCRL regulation in innate-like B cells
Randall S Davis
Annual Review of Immunology
|
January 5, 2007
Fc receptor-like molecules
Randall S Davis
Frontiers in Immunology
|
November 9, 2020
Roles for the FCRL6 Immunoreceptor in Tumor Immunology
Randall S Davis
JAMA
|
January 6, 2011
Unraveling the molecular pathogenesis of chronic lymphocytic leukemia: dissecting a microRNA regulatory network
Daniel J Allendorf, Randall S Davis
Proceedings of the National Academy of Sciences of the United States of America
|
March 20, 2013
FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling
Zilu Zhu, Ran Li, Hao Li, et al.
Leukemia & Lymphoma
|
October 14, 2014
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
Racquel D Innis-Shelton, Randall S Davis, Lawrence Lamb, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Evidence for Extensive Duplication and Subfunctionalization of <i>FCRL6</i> in Armadillo (<i>Dasypus novemcinctus</i>)
Maria Carolina Matos, Ana Pinheiro, Randall S Davis, et al.
Blood
|
September 13, 2011
FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling
Hae Won Sohn, Peter D Krueger, Randall S Davis, et al.
Clinical Case Reports
|
June 8, 2017
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia
Lauren K Shea, Fady M Mikhail, Andres Forero-Torres, et al.
European Journal of Immunology
|
November 11, 2008
FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia
Daniel M Schreeder, Jicun Pan, Fu Jun Li, et al.
Page
of 6